exRNA isolation from plasma or serum is challenging, partly because of the low abundance of exRNAs but also because contaminants from blood such as heme and immunoglobulin G (IgG) can inhibit PCR (7) (8) . In addition, RNA species are carried in the plasma or serum via different mechanisms, such as within RNA-protein complexes or extracellular vesicles (4, (9) (10) (11) (12) . Different forms of stable exRNAs might therefore possess different levels of resistance and vulnerability to particular isolation methods.
Commercially available kits that simplify and accelerate the process of exRNA isolation have become frequently used tools in circulating exRNA research. Whether isolation kits differ in their overall ability to isolate exRNA and remove contaminants from plasma samples, as well as their potential preferences for specific RNA species, has not been directly evaluated. Such testing is critical since systemic biases would complicate interpretation of results and comparisons between experiments in which different exRNA isolation kits are used or when no information is provided regarding the RNA isolation method used (1) .
Here, we evaluated seven widely available and commonly used exRNA isolation kits (Table 1 ) on their overall recovery rate of synthetic RNA, ability to recover synthetic RNA of different sizes, plasma exRNA yield and purity, and amplification efficiency of plasma exRNA samples purified using these kits.
To assess the overall recovery rate and size bias of the kits, we used 6 synthetic RNAs ranging in length from 200 to 6000 nucleotides (Agilent RNA 6000 Nano Ladder; Agilent Technologies, Waldbronn, Germany). As shown in Figure 1A, While the MagMAX, Quick-RNA, DirectZol, miRNeasy, and mirVana kits showed comparable recovery of RNA of all lengths ( Figure 1B) , there was a significant loss of 4000 and 6000 nucleotide RNAs from RNA samples isolated by the miRCURY-Biofluids kit. This is consistent with the kit's specification for isolating RNA <1000 nucleotides in length, though the 2000 nucleotide band was still present in the recovered RNA. Notably, RNA bands ≥2000 nucleotides were largely absent from RNA samples recovered by the RNAdvance kit.
To compare kit performance on plasma exRNA purification, three biological replicates were performed with each kit using plasma from a single blood draw. RNA isolation was performed using input and elution volumes and protocols recommended by the manufacturers (Table 1) . Purified RNA samples were quantified using the Qubit RNA HS Assay (Life Technologies, Thermo Fisher Scientific). exRNA yield per prep ranged from 1.65 ± 0.26 ng (mean ± SEM) for the MagMAX kit to 35.17 ± 22.09 ng for the RNAdvance kit (Supplementary  Table S1 ). exRNA yield per 1 mL plasma ( Figure 1C) Commercial kits we tested are grouped according to purification method. Manufacturer information and RNA size purified in manufacturers' specifications are indicated. Plasma input and elution volumes used in this study are also shown. The high reading seen with the RNAdvance may be partly due to contamination from the lysis buffer. RNAdvance lysis buffer alone results in a high background reading in the Qubit Assay (58.7 ± 0.9 pg/mL) (mean ± SEM; 3 technical replicates), corresponding to an RNA concentration of 4.4 ng/ mL. The MagMAX lysis buffer also generated a Qubit reading of 22 pg/mL, while the same volume of lysis buffers from the other kits was not measurable by the Qubit Assay.
DNA contamination was detected in samples prepared by all seven kits using the Qubit DNA HS Assay. DNA contamination ranged from 1.2 ± 0.5 ng per 1 mL plasma for the MagMAX kit to 12.9 ± 4.7 ng per 1 mL plasma from the RNAdvance kit ( Figure 1D and Supplementary Table S1 ). In addition, PCR amplification of b-actin (ACTB) was positive for samples purified by the MagMAX, miRCURY-Biofluids, Quick-RNA, DirectZol, and mirVana kits (Supplementary Figure S1 ).
To assess the composition and ability to amplify RNA species from purified exRNA samples, we performed reverse transcription and PCR (RT-PCR) targeting hsa-miR-16, hsa-miR-150, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and ACTB ( Figure  1E ). RNA isolated using the miRNeasy kit was readily amplified for both miRNA and mRNA targets. While exRNA purified by the mirVana kit had the highest amplification for miRNAs, and the RNAdvance, miRCURYBiofluids, and DirectZol kits also showed robust amplification for miRNAs, they failed to readily amplify mRNAs. In contrast, exRNA prepared with the Quick-RNA kit had good amplification for mRNAs but not miRNAs. exRNA from the MagMAX kit failed to amplify miRNAs and mRNAs. To determine if an RT-PCR inhibitor was present in purified exRNA samples, we spiked synthetic EGFP-zgpr125 RNA into purified exRNA samples and compared its amplification to water containing the same concentration of the RNA spike-in. EGFP amplification levels were similar to that of spike-in alone for the miRCURY-Biofluids, Quick-RNA, and mirVana exRNA samples, slightly decreased for the RNAdvance and miRNeasy samples, and greatly reduced for the MagMAX and DirectZol samples (Supplementary Figure S2) .
Our study provides a comparative evaluation of seven RNA isolation kits (Table  2 ). Although these kits had good overall performance in recovering synthetic RNAs (≥50% recovery), some displayed biases in the length of RNAs that could be isolated. exRNA yields from plasma differed widely depending on the kit used, and some kits might introduce contaminants that could falsely increase Qubit RNA Assay readings. In addition, DNA contamination was present at different levels in all purified RNA samples. Differences in RT-PCR amplification among exRNA samples were apparent, partly due to the presence of RT-PCR inhibitors in some exRNA samples.
Most critically, exRNA samples purified with the majority of kits displayed ampli- Ladder recovery, size bias, extracellular RNA (exRNA) yield, cell-free DNA (cfDNA) co-purification, and reverse transcription PCR (RT-PCR) for microRNAs (miRNAs), messenger RNAs (mRNAs), and spike-in RNA of each kit were evaluated based on following criteria: For ladder recovery, "+++," "++," "+," and "-" denote "≥80%," "60%-80%," "40%-60%," and "<40%" recovery, respectively. For ladder size bias, "+++," "++," "+," and "-" denote "full range," "loss of 6 kb," "loss of ≥4 kb," and "loss of ≥2 kb," respectively. For RNA yield per 1 mL plasma, "+++," "++," "+," and "-" denote "≥50 ng," " 20-50 ng," "10-20 ng," and "<10 ng," respectively. For cfDNA amount per 1 mL plasma, "+++," "++," "+," and "-" denote "≥10 ng," "5-10 ng," "1-5 ng," and "<1 ng," respectively. For RT-PCR, "+++," "++," "+," and "-" denote "good," "moderate," "weak," and "not detected" amplification, respectively. * indicates possible overestimation of exRNA yields, due to the high Qubit reading of the lysis buffer used in the indicated kits. 
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